Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Cysticercosis Differential Diagnoses

  • Author: Mossammat M Mansur, MD, MBBS; Chief Editor: Pranatharthi Haran Chandrasekar, MBBS, MD  more...
 
Updated: Oct 05, 2015
 
 

Differential Diagnoses

 
 
Contributor Information and Disclosures
Author

Mossammat M Mansur, MD, MBBS Attending Physician, Nassau ID Physicians

Mossammat M Mansur, MD, MBBS is a member of the following medical societies: Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Coauthor(s)

Martin Montes, MD Fellow, Department of Medicine, Section of Infectious Disease, Baylor College of Medicine; Research Associate, Instituto de Medicina Tropical ‘Alexander von Humboldt’, Universidad Peruana Cayetano Heredia, Perú

Disclosure: Nothing to disclose.

Linda S Yancey, MD Consulting Staff, West Houston Infectious Diseases

Linda S Yancey, MD is a member of the following medical societies: American College of Physicians, American Medical Association, Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

John W King, MD Professor of Medicine, Chief, Section of Infectious Diseases, Director, Viral Therapeutics Clinics for Hepatitis, Louisiana State University Health Sciences Center; Consultant in Infectious Diseases, Overton Brooks Veterans Affairs Medical Center

John W King, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Federation for Medical Research, Association of Subspecialty Professors, American Society for Microbiology, Infectious Diseases Society of America, Sigma Xi

Disclosure: Nothing to disclose.

Chief Editor

Pranatharthi Haran Chandrasekar, MBBS, MD Professor, Chief of Infectious Disease, Program Director of Infectious Disease Fellowship, Department of Internal Medicine, Wayne State University School of Medicine

Pranatharthi Haran Chandrasekar, MBBS, MD is a member of the following medical societies: American College of Physicians, American Society for Microbiology, International Immunocompromised Host Society, Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Additional Contributors

David Hall Shepp, MD Program Director, Fellowship in Infectious Diseases, Department of Medicine, North Shore University Hospital; Associate Professor, New York University School of Medicine

David Hall Shepp, MD is a member of the following medical societies: Infectious Diseases Society of America

Disclosure: Received salary from Gilead Sciences for management position.

Acknowledgements

The authors and editors would like to acknowledge Dr. Martin Montes, Dr. Clinton White Jr., and Dr. Thomas P. Giordano, who were the original authors of this article. They would also like to acknowledge the prior contributions of Dr. John W King to the development and writing of this article.

References
  1. Schantz PM, Moore AC, Muñoz JL, Hartman BJ, Schaefer JA, Aron AM, et al. Neurocysticercosis in an Orthodox Jewish community in New York City. N Engl J Med. 1992 Sep 3. 327(10):692-5. [Medline].

  2. Sorvillo FJ, DeGiorgio C, Waterman SH. Deaths from cysticercosis, United States. Emerg Infect Dis. 2007 Feb. 13(2):230-5. [Medline].

  3. Wu W, Qian X, Huang Y, Hong Q. A review of the control of clonorchiasis sinensis and Taenia solium taeniasis/cysticercosis in China. Parasitol Res. 2012 Oct 5. [Medline].

  4. de Bittencourt PR, Adamolekum B, Bharucha N, et al. Epilepsy in the tropics: I. Epidemiology, socioeconomic risk factors, and etiology. Epilepsia. 1996 Nov. 37(11):1121-7. [Medline].

  5. Wallin MT, Kurtzke JF. Neurocysticercosis in the United States: review of an important emerging infection. Neurology. 2004 Nov 9. 63(9):1559-64. [Medline].

  6. Ong S, Talan DA, Moran GJ, et al. Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis. 2002 Jun. 8(6):608-13. [Medline].

  7. Bern C, Garcia HH, Evans C, et al. Magnitude of the disease burden from neurocysticercosis in a developing country. Clin Infect Dis. 1999 Nov. 29(5):1203-9. [Medline].

  8. Malik AM, Shamim MD, Ahmad M, Abdali N. Neurocysticercosis presenting as focal hydrocephalus. BMJ Case Rep. 2014 Jun 24. 2014:[Medline].

  9. Prasad R, Shambhavi, Mishra OP, Upadhyay SK, Singh TB, Singh UK. Cognitive and Behaviour Dysfunction of Children with Neurocysticercosis: A Cross-Sectional Study. J Trop Pediatr. 2014 Jun 13. [Medline].

  10. Othman AA, Bruschi F, Ganna AA. Helminth parasitic infections of the central nervous system: a diagnostic approach. J Egypt Soc Parasitol. 2014 Apr. 44(1):55-70. [Medline].

  11. Del Brutto OH, Rajshekhar V, White AC Jr, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology. 2001 Jul 24. 57(2):177-83. [Medline].

  12. Fleury A, Hernandez M, Fragoso G, et al. Detection of secreted cysticercal antigen: a useful tool in the diagnosis of inflammatory neurocysticercosis. Trans R Soc Trop Med Hyg. 2003 Sep-Oct. 97(5):542-6. [Medline].

  13. Cavellani CL, Corrêa RR, Ferraz ML, Rocha LP, Faleiros AC, Lino Junior Rde S, et al. Influence of gender on cardiac and encephalic inflammation in the elderly with cysticercosis: a case control study. J Trop Med. 2012. 2012:540858. [Medline]. [Full Text].

  14. White AC Jr, Robinson P, Kuhn R. Taenia solium cysticercosis: host-parasite interactions and the immune response. Chem Immunol. 1997. 66:209-30. [Medline].

  15. Garcia HH, Pretell EJ, Gilman RH, Martinez SM, Moulton LH, Del Brutto OH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med. 2004 Jan 15. 350(3):249-58. [Medline].

  16. Kelley R, Duong DH, Locke GE. Characteristics of ventricular shunt malfunctions among patients with neurocysticercosis. Neurosurgery. 2002 Apr. 50(4):757-61; discussion 761-2. [Medline].

  17. Garcia HH, Pretell EJ, Gilman RH, et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med. 2004 Jan 15. 350(3):249-58. [Medline].

  18. Garcia HH, Gonzales I, Lescano AG, Bustos JA, Zimic M, Escalante D, et al. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial. Lancet Infect Dis. 2014 Aug. 14(8):687-95. [Medline].

  19. Del Brutto OH, Castillo PR, Mena IX, et al. Neurocysticercosis among patients with cerebral gliomas. Arch Neurol. 1997 Sep. 54(9):1125-8. [Medline].

  20. Del Brutto OH. Neurocysticercosis. Semin Neurol. 2005 Sep. 25(3):243-51. [Medline].

  21. Del Brutto OH, Santibanez R, Noboa CA, et al. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology. 1992 Feb. 42(2):389-92. [Medline].

  22. Garcia HH, Gilman RH, Tovar MA, et al. Factors associated with Taenia solium cysticercosis: analysis of nine hundred forty-six Peruvian neurologic patients. Cysticercosis Working Group in Peru (CWG). Am J Trop Med Hyg. 1995 Feb. 52(2):145-8. [Medline].

  23. García HH, Del Brutto OH. Imaging findings in neurocysticercosis. Acta Trop. 2003 Jun. 87(1):71-8. [Medline].

  24. [Guideline] García HH, Evans CA, Nash TE, et al. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev. 2002 Oct. 15(4):747-56. [Medline].

  25. Gordon E, Cartwright M, Avasarala J. Ventricular obstruction from neurocysticercosis. Arch Neurol. 2005 Jun. 62(6):1018. [Medline].

  26. Gravori T, Steineke T, Bergsneider M. Endoscopic removal of cisternal neurocysticercal cysts. Technical note. Neurosurg Focus. 2002 Jun 15. 12(6):e7. [Medline].

  27. Immunetics, Inc. Qualicode Cysticecosis Western Blot Kit. 1997. [Full Text].

  28. Kraft R. Cysticercosis: an emerging parasitic disease. Am Fam Physician. 2007 Jul 1. 76(1):91-6. [Medline].

  29. Nainiwal S, Chand M, Verma L, et al. Intraocular live cysticercus larva. Ophthalmic Surg Lasers Imaging. 2003 Nov-Dec. 34(6):464-6. [Medline].

  30. Ramakrishnan P, Bahirwani S, Balaji P. Cysticercosis of the masseter. Indian J Dent Res. 2012 May. 23(3):436. [Medline].

  31. Salinas R, Counsell C, Prasad K, et al. Treating neurocysticercosis medically: a systematic review of randomized, controlled trials. Trop Med Int Health. 1999 Nov. 4(11):713-8. [Medline].

  32. Sharma T, Sinha S, Shah N, et al. Intraocular cysticercosis: clinical characteristics and visual outcome after vitreoretinal surgery. Ophthalmology. 2003 May. 110(5):996-1004. [Medline].

  33. Sotelo J, Escobedo F, Penagos P. Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial. Arch Neurol. 1988 May. 45(5):532-4. [Medline].

  34. Sundaram PM, Jayakumar N, Noronha V. Extraocular muscle cysticercosis - a clinical challenge to the ophthalmologists. Orbit. 2004 Dec. 23(4):255-62. [Medline].

  35. White AC Jr. Neurocysticercosis: a major cause of neurological disease worldwide. Clin Infect Dis. 1997 Feb. 24(2):101-13; quiz 114-5. [Medline].

  36. White AC Jr, Robinson P, Kuhn R. Taenia solium cysticercosis: host-parasite interactions and the immune response. Chem Immunol. 1997. 66:209-30. [Medline].

Previous
Next
 
Nonenhanced CT scan of the brain demonstrates the multiple calcified lesions of inactive parenchymal neurocysticercosis.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.